An article published by AARP online stated that visceral fat—belly fat, in plain English—interferes with liver function. In particular, it hampers the processing of cholesterol and insulin—and may also compromise the function of other tissues and systems. In December a study conducted at the VU University Medical Center in Amsterdam found links between belly fat and capillary inflammation (a contributor to heart disease) and between belly fat and insulin resistance (a precursor to diabetes).
Reliv has an amazing new product which can help with this dangerous condition!
Reliv International Releases Breakthrough Nutritional Product; GlucAffect™ Addresses Leading Factors of Metabolic Syndrome
Reliv International, Inc. (NASDAQ:RELV), a developer, manufacturer and marketer of science-based nutritional supplements today introduced GlucAffect™, a powder-based supplement clinically shown, along with proper diet and exercise, to reduce blood glucose levels and help control weight.
In an eight-week clinical study of 50 overweight individuals with moderately elevated blood glucose levels, subjects taking GlucAffect lowered their fasting blood glucose by an average of 30 percent. Those individuals also lost an average of 16 pounds. Both results are statistically significant when compared with results for the control group.
One of GlucAffect’s main active ingredients, Pycnogenol®, is an antioxidant clinically shown to help lower high blood glucose levels and provide other health benefits.
Elevated blood glucose levels and being overweight are key factors in metabolic syndrome, which dramatically increases the likelihood of developing diseases such as diabetes, heart disease and stroke. According to the American Heart Association, an estimated 47 million U.S. residents have the metabolic syndrome or nearly 1 in 4 American adults.
“Metabolic syndrome is a serious, emerging health concern among the medical community, and physicians are more frequently looking to nutritional science as a complement to traditional care and prescriptive remedies. We see the study results of GlucAffect as a significant development,” said Dr. Carl Hastings, vice chairman and chief scientific officer, Reliv.
GlucAffect comes in powder form and is blended with water, juice, coffee or milk to make a drink. GlucAffect retails at $60 per can and provides 42 servings. The product is available through Reliv’s U.S. distributor network, part of an international contingent of approximately 69,000 distributors in 13 countries.
No other product available on the market includes the combination of innovative ingredients found in GlucAffect. Dr. Hastings added, “Ingredients were carefully selected based upon research, extensive testing, processes and controls instituted by Reliv’s team of nutritional scientists.”
No comments:
Post a Comment